Inotiv is a leading CRO dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services.
Since 1974, Inotiv has been at the forefront of research across a diverse range of therapeutic areas, including cardiovascular, gastrointestinal, hepatic, infectious disease, inflammation/immunology, metabolic/diabetic disease, neuroscience, oncology, pulmonary, and renal. Our team of leading scientists and researchers possesses a deep understanding of these diverse areas and is committed to developing new and effective treatment options for a variety of conditions. We leverage cutting-edge technology and collaborate with renowned institutions to bring hope and progress to patients living with complex diseases.
Copyright © 2024 Inotiv. All Rights Reserved.